Propionic Acid → N-{2-[5-(1-Methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3,4-dihydro-2H-[1,7]naphthyridin-1-yl]-ethyl}-propionamide
反応式
Cl.[NH2:2][CH2:3][CH2:4][N:5]1[C:14]2[C:9](=[C:10]([C:15]3[CH:16]=[C:17]4[C:22](=[CH:23][CH:24]=3)[N:21]([CH3:25])[C:20](=[O:26])[CH2:19][CH2:18]4)[CH:11]=[N:12][CH:13]=2)[CH2:8][CH2:7][CH2:6]1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CCN(C(C)C)C(C)C.[C:58](O)(=[O:61])[CH2:59][CH3:60].C([O-])(O)=O.[Na+]>CN(C=O)C.CCOC(C)=O>[CH3:25][N:21]1[C:22]2[C:17](=[CH:16][C:15]([C:10]3[CH:11]=[N:12][CH:13]=[C:14]4[C:9]=3[CH2:8][CH2:7][CH2:6][N:5]4[CH2:4][CH2:3][NH:2][C:58](=[O:61])[CH2:59][CH3:60])=[CH:24][CH:23]=2)[CH2:18][CH2:19][C:20]1=[O:26]参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of 6-[1-(2-amino-ethyl)-1,2,3,4-tetrahydro-[1,7]naphthyridin-5-yl]-1-methyl-3,4-dihydro-1H-quinolin-2-one hydrochloride (example 12, 0.037 g, 0.099 mmol) in dry DMF (1.5 mL) were added TBTU ((O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate) 0.038 g, 0.119 mmol), Hünig's base (0.032 g, 0.248 mmol) and propionic acid (0.015 g, 0.198 mmol) and the reaction mixture was stirred at room temperature over night. Then, the reaction mixture was diluted with EtOAc, poured into sat. NaHCO3 solution (5 mL) and extracted with EtOAc (2×10 mL). Combined organics were dried over Na2SO4, filtered and evaporated to dryness. The residue was purified by silica gel flash chromatography eluting with a 0 to 10% MeOH (1% NH4OH)-DCM gradient to give the title compound (0.023 g, 59%) as a yellow solid. MS: 393.2 (M+H+).
後処理
- extractionextracted with EtOAc (2×10 mL)
- dry with materialCombined organics were dried over Na2SO4
- filtrationfiltered
- customevaporated to dryness
- customThe residue was purified by silica gel flash chromatography
- washeluting with a 0 to 10% MeOH (1% NH4OH)-DCM gradient
出典と根拠
- ORDレコード
- ord-8ba60999933746dda297e056e8e88497
- 出典データセット
- uspto-grants-2016_05
- 特許番号
- US09353081B2
反応ノート
読み込み中…